ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI ... or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins.

Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...